000			01709 a2200445 4500
005			20250514191523.0
264		0	_c20040916
008			200409s 0 0 eng d
022			_a0165-0270
024	7		_a10.1016/j.jneumeth.2004.01.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aKeswani, Sanjay C
245	0	0	_aThe use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures. _h[electronic resource]
260			_bJournal of neuroscience methods _cJul 2004
300			_a193-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aCell Culture Techniques _xmethods
650	0	4	_aCells, Cultured
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation, Preclinical _xmethods
650	0	4	_aFetus
650	0	4	_aGAP-43 Protein _xgenetics
650	0	4	_aGanglia, Spinal _xcytology
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aNerve Degeneration _xdrug therapy
650	0	4	_aNeurons _xcytology
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRats
650	0	4	_aReproducibility of Results
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction _xinstrumentation
650	0	4	_aTacrolimus _xpharmacology
650	0	4	_aZalcitabine _xantagonists & inhibitors
700	1		_aRosenberg, Brian
700	1		_aHoke, Ahmet
773	0		_tJournal of neuroscience methods _gvol. 136 _gno. 2 _gp. 193-5
856	4	0	_uhttps://doi.org/10.1016/j.jneumeth.2004.01.004 _zAvailable from publisher's website
999			_c14890544 _d14890544